pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
pharmadog news

Browse

1,544 stories matching this filter · ← front page

★ save view↓export CSV
rangeto
sort
recentoldestsourcealpha
source
STAT786Endpoints593BioPharma Dive228onclive165BioSpace63Fierce Biotech63raps25
therapy area
allOncology81Cardiology27Psychiatry & CNS21Vaccines17Immunology17Rare Disease12Hepatology6Hematology
  • STAT+: Private Medicare plans erect barriers to rehab care in pursuit of profit, federal investigators find
    Federal investigation finds Medicare Advantage insurers block rehab care for older adults, only to reverse denials on appeal.
    STAT · 1mo ago↗ source
  • Exclusive: Genentech closes infectious disease unit in wave of research layoffs
    Roche's Genentech underwent another round of layoffs this week in its early research and development group, Endpoints News has learned, which included shuttering two research units and the departur…
    Endpoints · 1mo ago↗ source
  • Diabetes association leader apologizes for expulsion of members, pledges to rebuild trust
    The American Diabetes Association CEO apologizes to five members kicked out of annual convention for distributing protest literature, launches review of what went awry.
← prev
page 26 of 62
next →
6
Pulmonology5
Infectious Disease4
Ophthalmology3
Dermatology2
STAT · 1mo ago
↗ source
  • Rare disease biotech Beren adds $300M from new financings
    Anxiously awaiting an FDA decision this fall, Beren Therapeutics has added $300 million in new capital to help launch its rare disease drug. The biotech announced Wednesday that it raised $135 ...
    Endpoints · 1mo ago↗ source
  • Parabilis CEO Mathai Mammen on biotech's record IPO
    Parabilis Medicines cemented the largest biotech IPO in industry history on Wednesday with its $670 million debut on the Nasdaq. But the Cambridge, MA-based drug developer won't be celebrating at…
    Endpoints · 1mo ago↗ source
  • STAT+: Your sepsis algorithm shouldn’t require a time machine
    In this edition of AI Prognosis: Quirky medical data tripping up sepsis algorithms, AI scribes for patients, and some AI biotech news.
    STAT · 1mo ago↗ source
  • Novartis and Orionis strike second molecular glue deal for $40M upfront
    Novartis is doubling down on its partnership with Orionis Biosciences in a deal worth $40 million upfront and up to $1.4 billion spread across milestones. The Boston and Belgian biotech will ...
    Endpoints · 1mo ago↗ source
  • SonoThera raises $125M for non-viral gene therapy approach
    SonoThera has secured $125 million to take its ultrasound-based gene therapy technology into the clinic. The company is focused on two lead programs in Duchenne muscular dystrophy and autosomal d…
    Endpoints · 1mo ago↗ source
  • OB-GYN association, deviating from CDC guidance, issues its own vaccine recommendations
    The American College of Obstetricians and Gynecologists has released a recommended vaccine schedule during pregnancy, one that diverges from CDC guidance.
    STAT · 1mo ago↗ source
  • STAT+: Hope for Kendall Square’s lab market
    Drug pricing in Europe, AI deals for VC firms, and more biotech news from The Readout
    STAT · 1mo ago↗ source
  • Shattuck raises $75M; Servier inks neuro ASO pact with n-Lorem Foundation
    Shattuck Labs initiates $75M public offering: The US biotech {$STTK} is selling over 10.5 million shares for $4 apiece, and issuing pre-funded warrants for certain investors. The offering is set to…
    Endpoints · 1mo ago↗ source
  • Biotech pay analysis: 12 execs with $35M+ M&A golden parachutes
    A dozen biotech executives took home nearly $1 billion worth of exit packages from selling their companies, an Endpoints News analysis found. The drug industry is undergoing a historic stretch of…
    Endpoints · 1mo ago↗ source
  • STAT+: Pharmalittle: We’re reading about U.S. pressure on European drug prices, longer shortages, and more
    A new analysis found the average drug shortage in 2025 had lasted 5.3 years, exceeding the 4.3 years seen in 2024
    STAT · 1mo ago↗ source
  • DOJ reaches second settlement on youth gender care
    A new era of American sunscreen, NIAID taps new acting director, and more health news from Morning Rounds
    STAT · 1mo ago↗ source
  • Ethyreal lands $101M to treat both Graves' and thyroid eye disease
    A biotech backed by Atlas Venture and Medicxi uncloaked on Wednesday morning to tackle the related autoimmune conditions Graves' disease and thyroid eye disease, and the startup plans to enter the…
    Endpoints · 1mo ago↗ source
  • Sanofi to mull riliprubart’s future after stopping late-stage nerve disease study
    Sanofi is ending a Phase 3 trial of its antibody drug in a rare neurological disorder after an independent committee said the study was unlikely to show sufficient efficacy. The broader future of…
    Endpoints · 1mo ago↗ source
  • Are Republicans turning against medications for treating opioid addiction?
    Federal actions and proposals have reignited debate over methadone and buprenorphine, worrying addiction experts and patient groups.
    STAT · 1mo ago↗ source
  • STAT+: As the U.S. looks on, European countries feel growing pressure on drug prices
    In Europe, two divergent paths are emerging as countries grapple with what to do about drug prices, affecting both pharma and patients — and testing the influence of the U.S.
    STAT · 1mo ago↗ source
  • Opinion: Even in abortion-protecting states, teens face unnecessary barriers to care
    “Legal protection for abortion does not mean equitable access for minors,” a pediatrics resident writes.
    STAT · 1mo ago↗ source
  • Opinion: ‘They all think I’m insane’: What it’s like to start medical residency at 72
    “I know what I’m getting into”: Dawn Zuidgeest-Craft on starting medical residency at almost 73.
    STAT · 1mo ago↗ source
  • Parabilis' $670M IPO sets new biotech record, will fund cancer drug
    Despite all the noise around massive upcoming IPOs for AI giants, a drug developer was able to attract enough investor interest to achieve the biggest Nasdaq debut the biopharma industry has ever s…
    Endpoints · 1mo ago↗ source
  • STAT+: The shortage of many medicines in the U.S. remains a ‘systemic’ problem, a new analysis finds
    The number of prescription drug shortages in the U.S. fell by 23% last year, but a new analysis found other troubling signs about medicines in short supply.
    STAT · 1mo ago↗ source
  • STAT+: Trump’s health care affordability czar takes aim at hospitals
    Plus a buried alcohol study gets published, and a Biosecure update.
    STAT · 1mo ago↗ source
  • Diabetes Association in uproar after members expelled from annual meeting over protest of NIH cuts
    The condemnations keep coming after five diabetes experts were escorted out of an ADA meeting for handing out copies of an editorial criticizing federal research cuts.
    STAT · 1mo ago↗ source
  • FDA OKs first new sunscreen ingredient in more than 25 years
    Federal health regulators on Tuesday signed off on the first new sunscreen ingredient for the U.S. market in more than 25 years.
    STAT · 1mo ago↗ source